Skip to main content

Gen1E Lifesciences

Palo Alto, United States

GEn1E is a clinical-stage multi-target AI platform. They develop novel, next-gen, immunomodulators for rare & inflammatory diseases.

$5.5M raised
Dec 2025
Venture - Series Unknown

Top Investors

Khosla VenturesY CombinatorBossa InvestLeblon CapitalMilad Alucozai

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Gen1E Lifesciences

How much funding has Gen1E Lifesciences raised?
Gen1E Lifesciences has raised $5.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2025.
Who are Gen1E Lifesciences's investors?
Gen1E Lifesciences's investors include Khosla Ventures, Y Combinator, Bossa Invest, Leblon Capital, Milad Alucozai.
Where is Gen1E Lifesciences headquartered?
Gen1E Lifesciences is headquartered in Palo Alto, United States.
What does Gen1E Lifesciences do?
GEn1E is a clinical-stage multi-target AI platform. They develop novel, next-gen, immunomodulators for rare & inflammatory diseases.
What stage is Gen1E Lifesciences at?
Gen1E Lifesciences is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Gen1E Lifesciences — Funding & Investors." VCBacked, December 23, 2025, https://www.vcbacked.co/company/gen1e-lifesciences. Accessed July 1, 2026.
APA
VCBacked. (2025). Gen1E Lifesciences — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/gen1e-lifesciences
Wikipedia (cite web)
{{cite web |title=Gen1E Lifesciences — Funding & Investors |url=https://www.vcbacked.co/company/gen1e-lifesciences |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .